Atlas Trials

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT01392235 · COMPLETED

Trial details

NCT number
NCT01392235
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Start date
2011-07-01
Primary completion
2015-04-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.